Total Funding
36
Total FundingSeries C raised
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
137084
Iantech is a developer of a cataract treatment device.
Scott Chamness: Director and Engineering
Luke Clauson: COO & FounderPast Role: Dextera Surgical, Director of Engineering
About the Company
Iantech has developed advanced micro-interventional technology for cataract surgery. After 50 years of conventional phacoemulsification, Iantech introduces a micro-interventional technique designed to deliver energy-free endocapsular lens fragmentation, giving surgeons control, efficiency and new opportunities to improve their surgical
technique.
At Iantech, They are working to invent new surgical approaches which can reduce the global footprint of cataract blindness. Using smart, efficient and adaptable micro-interventional technology, Their team is building a new surgical platform to catalyze global outreach efforts as we fight the 25M blindness epidemic in the world
